| abstract |
The invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R is selected from the group consisting of H, F, Cl, —CF, —CH, —OH, —O (C-C1-6 alkyl), —O-cyclopropyl, O-CH-phenyl, —OC (H) F, and —OCF, R is selected from the group consisting of H and —CH, R is selected from the group consisting of H and —CH, provided that at least one of the group consisting of R and R represents H, and n is 1, 2 or 3, as diacylglycerol acyl transferase 1 (DGAT-1) inhibitors. The present invention also relates to a pharmaceutical composition containing the compound, and to the use of the compound as a medicament for the treatment of diabetes and / or obesity. |